Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Multi Hanna Kreasindo Tbk. (MHKI) vs Tempo Scan Pacific Tbk. (TSPC)

Multi Hanna Kreasindo Tbk.Trading
Tempo Scan Pacific Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Multi Hanna Kreasindo Tbk. dan Tempo Scan Pacific Tbk.: Multi Hanna Kreasindo Tbk. diperdagangkan di Rp133 (kapitalisasi pasar 506,25 M, volume 24 jam 958,3 rb), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.780 (kapitalisasi pasar 12,58 T, volume 24 jam 218,8 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 24,8× kapitalisasi pasar Multi Hanna Kreasindo Tbk., dan Multi Hanna Kreasindo Tbk. lebih aktif diperdagangkan (958,3 rb vs 218,8 rb). Mana yang lebih baik tergantung tujuan investasimu.

MHKITSPC
Kapitalisasi Pasar
506,25 M12,58 T
Volume
958,3 rb218,8 rb
Lot
9,58 rb2,19 rb
Perputaran
127,05 jt604,28 jt
Harga Rata-rata
132,582.761,8
Nilai Transaksi
127,05 jt604,28 jt
Harga Ekuilibrium Indikatif
1362.790
Volume Ekuilibrium Indikatif
63,9 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

MHKI
Lihat detail
TSPC
Lihat detail

Tentang Multi Hanna Kreasindo Tbk.

PT Multi Hanna Kreasindo Tbk (Company), was established on September 23, 2004 based on Deed of Notary Drajat Dramaji, S.H., No.165. The company became effective commercially on September 23, 2004. The parent entity of the Company is PT Multi Hanna Sinergitama and the ultimate beneficial owners of the Company are Mr. Shahabuddin and Mr. Alwi.

Selengkapnya di halaman MHKI

Tentang Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Selengkapnya di halaman TSPC